Announcement Össur hf. No. 3/2010
Reykjavik, 4 February 2010
SOLID OPERATIONS - 2009
Highlights:
Sales USD 331 million
Gradual increase in sales during the year
EBITDA margin 20%
Strong performance in Prosthetics
Second generation of Bionics launched
Enhanced sales platform in place
Listing on NASDAQ OMX Copenhagen
Guidance 2010:
Sales 3-4% LCY growth
EBITDA 8-10% LCY growth
Jon Sigurdsson, President & CEO, comments:
"The results for 2009 are good and show clearly the Company's strength. During the year we have seen the global economic turmoil having an impact on our customers and affecting some of our markets. However, Össur continues to be profitable and operations are sound. Our Bionic product line has gained further momentum through the launch of the second generation of the RHEO KNEE as well as the acceptance of the PROPRIO FOOT into the US reimbursement systems. In 2009 we have invested significantly in aligning our B&S business to take advantage of the prevailing market opportunity. We believe that 2010 will be an exciting year for Össur."
Össur Investor Meeting Thursday 4 February in Copenhagen
- Live webcast at 12:00 CET/ 11:00 GMT/ 6:00 EST
Thursday 4 February 2010 Jon Sigurdsson, President and CEO, and Hjorleifur Palsson, CFO, will host a meeting for investors, analysts and shareholders presenting and discussing the results of the fourth quarter and the year 2009. The meeting will be held in Copenhagen at the Radisson Blu Royal Hotel, Hammerichsgade 1, Copenhagen. The meeting will be conducted in English.
There will be a live broadcast from the meeting on the Össur website: www.ossur.com/investors
To participate in the meeting please call one of the following telephone numbers:
Europe: + 44 (0) 207 509 5139
The United States: +1 718 354 1226
Iceland: 800 9313
